The interaction leads to a reduction in tRNAPhe charging, which leads to decreased Phe incorporation into proteins in cell models and human post-mortem tissue of C9orf72 mutation positive ALS/FTD patients. The gene discussed is C9orf72; the disease is amyotrophic lateral sclerosis.